WazirX Lists Venom (VENOM), a Multi-Blockchain System with Dynamic Sharding Capabilities

The VENOM token has uses such as paying for transaction fees to maintain the network by validators, securing the network through POS mechanisms, and supporting validators by network participants through DePools staking.

The Venom blockchain, known for its multi-blockchain architecture with dynamic sharding capabilities, is set to join the WazirX ecosystem. The network boasts several features that cater to diverse applications, including low transfer fees, high scalability, Proof-of-Stake consensus, multi-signature wallets, and decentralized data storage. Moreover, its interoperability with other blockchains enables seamless asset and data transfers.

The VENOM token serves multiple purposes within the network, such as paying transaction fees to maintain the network by validators. It also secures the network through POS mechanisms and supports validators by network participants through DePools staking.

With the addition of VENOM, users will be able to trade the token on the platform soon, unlocking the opportunities presented by this asset. The listing of VENOM on WazirX marks another step in the exchange's commitment to providing its users with a diverse array of tokens, enabling them to expand their portfolio and explore different crypto assets.

Commenting on the listing, Rajagopal Menon, VP of Marketing at WazirX, said, "The VENOM network has already addressed several key issues in the crypto ecosystem, particularly scalability and transaction problems. It has a wide range of partnerships and is expanding rapidly, showcasing its popularity and growing user base. WazirX is thrilled to give users the chance to trade this token."

"Listing $VENOM on WazirX was a strategic move for our project, enabling us to connect with over 16 million users in India. This step is crucial in our efforts to drive blockchain innovation and expand our reach. It is helping Venom establish a much larger footprint in the most populous country in the world, significantly increasing our exposure," said Christopher Louis Tsu, CEO of Venom Foundation.